NOD1 receptor is up-regulated in diabetic human and murine myocardium.
about
Metainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune ResponsesAlpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.MicroRNA-495 inhibits the high glucose-induced inflammation, differentiation and extracellular matrix accumulation of cardiac fibroblasts through downregulation of NOD1.Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure.
P2860
NOD1 receptor is up-regulated in diabetic human and murine myocardium.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
NOD1 receptor is up-regulated in diabetic human and murine myocardium.
@en
type
label
NOD1 receptor is up-regulated in diabetic human and murine myocardium.
@en
prefLabel
NOD1 receptor is up-regulated in diabetic human and murine myocardium.
@en
P2093
P2860
P50
P356
P1433
P1476
NOD1 receptor is up-regulated in diabetic human and murine myocardium
@en
P2093
Eduardo López-Collazo
Gemma Benito
Ivette Pacheco
Javier Regadera
Juan P Velasco-Martín
María Fernández-Velasco
María Teresa Vallejo-Cremades
Noelia Agra
Paloma Martín-Sanz
Patricia Prieto
P2860
P304
P356
10.1042/CS20140180
P407
P577
2014-12-01T00:00:00Z